Covid-19 vaccines: Should we allow human challenge studies to infect healthy volunteers with SARS-CoV-2?BMJ. 2020 11 09; 371:m4258.BMJ
Links
MeSH
Pub Type(s)
Journal Article
Language
eng
PubMed ID
33168564
Citation
McPartlin, Seán O'Neill, et al. "Covid-19 Vaccines: Should We Allow Human Challenge Studies to Infect Healthy Volunteers With SARS-CoV-2?" BMJ (Clinical Research Ed.), vol. 371, 2020, pp. m4258.
McPartlin SO, Morrison J, Rohrig A, et al. Covid-19 vaccines: Should we allow human challenge studies to infect healthy volunteers with SARS-CoV-2? BMJ. 2020;371:m4258.
McPartlin, S. O., Morrison, J., Rohrig, A., & Weijer, C. (2020). Covid-19 vaccines: Should we allow human challenge studies to infect healthy volunteers with SARS-CoV-2? BMJ (Clinical Research Ed.), 371, m4258. https://doi.org/10.1136/bmj.m4258
McPartlin SO, et al. Covid-19 Vaccines: Should We Allow Human Challenge Studies to Infect Healthy Volunteers With SARS-CoV-2. BMJ. 2020 11 9;371:m4258. PubMed PMID: 33168564.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Covid-19 vaccines: Should we allow human challenge studies to infect healthy volunteers with SARS-CoV-2?
AU - McPartlin,Seán O'Neill,
AU - Morrison,Josh,
AU - Rohrig,Abie,
AU - Weijer,Charles,
Y1 - 2020/11/09/
PY - 2020/11/10/entrez
PY - 2020/11/11/pubmed
PY - 2020/11/12/medline
SP - m4258
EP - m4258
JF - BMJ (Clinical research ed.)
JO - BMJ
VL - 371
SN - 1756-1833
UR - https://www.unboundmedicine.com/medline/citation/33168564/Covid_19_vaccines:_Should_we_allow_human_challenge_studies_to_infect_healthy_volunteers_with_SARS_CoV_2
DB - PRIME
DP - Unbound Medicine
ER -